Netherlands Healthcare Diagnostics Market Growth, Size, Trends, Revenue and Future Outlook
Netherlands Healthcare Diagnostics Market Size- By Product Type, By Application, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Dec-2023 | Report ID: HLCA2380 | Pages: 1 - 104 | Formats*: |
| Category : Healthcare | |||
Netherlands Healthcare Diagnostics Market Introduction and Overview
According to SPER Market Research, the Netherlands Healthcare Diagnostics Market is estimated to reach USD XX billion by 2033 with CAGR of XX%.
The report includes an in-depth analysis of the Netherlands Healthcare Diagnostics Market, including market size and trends, product mix, applications, and supplier analysis. Tests known as in vitro diagnostics are used to identify illnesses, disorders, and infections in order to treat, cure, and prevent disease. Reagents and assays are required in order to diagnose a medical ailment. It examines tissue samples and bodily fluids that a patient may provide. The examinations may be carried out in labs, medical centres, or even homes. It comprises of a next-generation sequencing test that looks for genomic changes in a person's DNA.
- September 2022: Molecular diagnostics business SkylineDx, located in the Netherlands, introduced the CE-IVD distributable test kit Merlin Assay to the European market in September 2022. For the purpose of staging, this is an invasive surgical treatment that determines the metastatic spread of cancer.
- November 2022: Sense Biodetection (Sense) and R-Biopharm Nederland B.V. signed a strategic agreement for the non-exclusive distribution of Sense's instrument-free, point-of-care molecular testing platform, Veros, throughout the Netherlands, Belgium, and Luxembourg. With no external power requirements or reader constraints, Veros is the first and only self-contained, single-use COVID-19 diagnosis that can generate extremely accurate molecular results in around 15 minutes.
Market Opportunities and Challenges
The primary drivers of the clinical diagnostics market in the Netherlands are the aging population, increasing patient awareness of the value of laboratory testing, and the rise in the number of patients with infectious and chronic illnesses. The increasing prevalence of chronic illnesses and an aging population are placing a significant strain on the world's healthcare resources. A wide range of stakeholders are also placing more and more demands on the industry, including hospitals seeking faster, more accurate solutions, labs seeking ways to maximize their current resources, and health systems modifying their delivery models in an effort to reduce healthcare costs.
However, obstacles to the market's expansion would include a shortage of trained laboratory personnel, the high cost of sophisticated molecular diagnostics and in vitro diagnostics equipment, and the onerous premarket approval (PMA) & IVD labelling regulations. Traditional diagnostic techniques are facing challenges from the trend toward customized care and focused therapies. It is necessary to develop new technologies and procedures in order to make diagnostic tests more specialized and customized to the unique patient profiles. It can be difficult to increase patient knowledge and comprehension of the significance of diagnostic testing. Improved patient involvement is essential for early diagnosis, better chronic illness management, and preventative healthcare.
Market Competitive Landscape
The Healthcare diagnostics market seems to be competitive in the Netherlands. In order to increase their market shares, some of these players are utilising a variety of market strategies, including partnerships, collaborations, capacity expansion, mergers and acquisitions, and product launches. Major players are Fresenius SE & Co., Siemens Healthineers, GE Healthcare, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics and various others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product Type, By Application, By End-User |
| Regions covered | Amsterdam Metropolitan Area, Eindhoven Region, Flevoland, Gelderland, North Brabant, North Holland, Rotterdam, South Holland Utrecht Region, Zeeland |
| Companies Covered | Fresenius SE & Co., Siemens Healthineers, GE Healthcare, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics and various others. |
COVID-19 Impact on Netherlands Healthcare Diagnostics Market
The demand for diagnostic testing, including as PCR, antigen, and antibody tests, increased dramatically as a result of the Covid-19 outbreak. This heightened need for testing probably had an impact on the diagnostics sector as a whole. PCR testing for Covid-19 in particular has become essential for the diagnosis and surveillance of the virus in the field of molecular diagnostics. The dynamics of the market might have been affected by this focus on molecular diagnostics. The epidemic hastened the deployment of remote healthcare and telemedicine technologies. This change may have had an impact on diagnostic procedures, with a greater emphasis on remote testing and monitoring.
Key Target Audience:
- Healthcare Providers
- Laboratories and Pathologists
- Pharmaceutical Companies
- Healthcare Regulators and Policymakers
- Healthcare Professionals
- Health Insurance Companies
- Patients and Advocacy Groups
- Academic and Research Institutions
- Health Information Technology (HealthTech) Companies
Our in-depth analysis of the Netherlands Healthcare Diagnostics Market includes the following segments:
| By Product Type: |
|
| By Application: |
|
| By End-User: |
|
Key Topics Covered in the Report:
- Netherlands Healthcare Diagnostics Market Size (FY’2023-FY’2033)
- Overview of Netherlands Healthcare Diagnostics Market
- Segmentation of Netherlands Healthcare Diagnostics Market By Product Type (Instruments, Reagents and Other Products)
- Segmentation of Netherlands Healthcare Diagnostics Market By Application (Autoimmune Disease, Cardiology, Diabetes, Infectious Diseases, Oncology and Others)
- Segmentation of Netherlands Healthcare Diagnostics Market By End-User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Other End Users)
- Statistical Snap of Netherlands Healthcare Diagnostics Market
- Expansion Analysis of Netherlands Healthcare Diagnostics Market
- Problems and Obstacles in Netherlands Healthcare Diagnostics Market
- Competitive Landscape in the Netherlands Healthcare Diagnostics Market
- Impact of COVID-19 and Demonetization on Netherlands Healthcare Diagnostics Market
- Details on Current Investment in Netherlands Healthcare Diagnostics Market
- Competitive Analysis of Netherlands Healthcare Diagnostics Market
- Prominent Players in the Netherlands Healthcare Diagnostics Market
- SWOT Analysis of Netherlands Healthcare Diagnostics Market
- Netherlands Healthcare Diagnostics Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Netherlands Healthcare Diagnostics Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Netherlands Healthcare Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Netherlands Healthcare Diagnostics Market
7. Netherlands Healthcare Diagnostics Market, By Product Type (USD Million)
7.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Product Type, 2023-20337.2. Instruments7.3. Reagents7.4. Other Products
8. Netherlands Healthcare Diagnostics Market, By Application (USD Million)
8.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Product Type, 2023-20338.2. Autoimmune Disease8.3. Cardiology8.4. Diabetes8.5. Infectious Diseases8.6. Oncology8.7. Others
9. Netherlands Healthcare Diagnostics Market, By End-User (USD Million)
9.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Distribution Channel, 2023-20339.2. Diagnostic Laboratory9.3. Hospital Laboratory9.4. Point-of-care Testing9.5. Other End Users
10. Netherlands Healthcare Diagnostics Market Forecast, 2019-2033 (USD Million)
10.1. Netherlands Healthcare Diagnostics Market Size and Market Share
11. Netherlands Healthcare Diagnostics Market, By Product Type, 2019-2033 (USD Million)
11.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Product Type (2019-2026)11.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Product Type (2027-2033)
12. Netherlands Healthcare Diagnostics Market, By Application , 2019-2033 (USD Million)
12.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Application (2019-2026)12.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Application (2027-2033)
13. Netherlands Healthcare Diagnostics Market, By End-User , 2019-2033 (USD Million)
13.1. Netherlands Healthcare Diagnostics Market Size and Market Share By End-User (2019-2026)13.2. Netherlands Healthcare Diagnostics Market Size and Market Share By End-User (2027-2033)
14. Netherlands Healthcare Diagnostics Market, By Region, 2019-2033 (USD Million)
14.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Region (2019-2026)14.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Region (2027-2033)14.3. Netherlands14.3.1. Amsterdam Metropolitan Area14.3.2. Eindhoven Region14.3.3. Flevoland14.3.4. Gelderland14.3.5. North Brabant14.3.6. North Holland14.3.7. Rotterdam14.3.8. South Holland14.3.9. Utrecht Region14.3.10. Zeeland
15. Company Profile
15.1. Abbott Laboratories15.1.1. Company details15.1.2. Financial outlook15.1.3. Product summary15.1.4. Recent developments15.2. Becton15.2.1. Company details15.2.2. Financial outlook15.2.3. Product summary15.2.4. Recent developments15.3. Bio-Rad Laboratories Inc.15.3.1. Company details15.3.2. Financial outlook15.3.3. Product summary15.3.4. Recent developments15.4. Danaher Corporation15.4.1. Company details15.4.2. Financial outlook15.4.3. Product summary15.4.4. Recent developments15.5. Fresenius SE & Co15.5.1. Company details15.5.2. Financial outlook15.5.3. Product summary15.5.4. Recent developments15.6. GE Healthcare15.6.1. Company details15.6.2. Financial outlook15.6.3. Product summary15.6.4. Recent developments15.7. Roche Diagnostics15.7.1. Company details15.7.2. Financial outlook15.7.3. Product summary15.7.4. Recent developments15.8. Qiagen15.8.1. Company details15.8.2. Financial outlook15.8.3. Product summary15.8.4. Recent developments15.9. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Netherlands Healthcare Diagnostics Market is projected to reach USD XX billion by 2033, growing at a CAGR of XX% during the forecast period.
Netherlands Healthcare Diagnostics Market grew in market size from 2023. The Market is expected to reach USD XX billion by 2033, at a CAGR of XX% during the forecast period.
Netherlands Healthcare Diagnostics Market CAGR of XX% during the forecast period.
You can get the sample pages by clicking the link -Click Here
Netherlands Healthcare Diagnostics Market size is USD XX billion from 2023 to 2033.
Netherlands Healthcare Diagnostics Market Segment is Covered By Product Type, By Application, By End-User
The Europe region is anticipated to have the highest market share in Netherlands Healthcare Diagnostics Market.
The key players in the market include Companies Covered Fresenius SE & Co., Siemens Healthineers, GE Healthcare, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics and various others.
Netherlands Healthcare Diagnostics Market, including market size and trends, product mix, applications, and supplier analysis. Tests known as in vitro diagnostics are used to identify illnesses, disorders, and infections in order to treat, cure, and prevent disease.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
